Literature DB >> 16796696

The effect of intracavernosal growth differentiation factor-5 therapy in a rat model of cavernosal nerve injury.

Thomas M Fandel1, Anthony J Bella, Kavirach Tantiwongse, Maurice Garcia, Lora Nunes, Joachim W Thüroff, Emil A Tanagho, Jens Pohl, Tom F Lue.   

Abstract

OBJECTIVE: To determine whether the intracavernosal application of growth differentiation factor-5 (GDF-5) influences nerve regeneration and erectile function after cavernosal nerve injury in a rat model.
MATERIALS AND METHODS: Thirty-two male Sprague-Dawley rats were randomly divided into four equal groups: eight had a sham operation (uninjured controls), while 24 had bilateral cavernosal nerve crush. The crush-injury groups were treated at the time of injury with an impregnated collagen sponge implanted into the right corpus cavernosum. The sponge contained no GDF-5 (injured controls), 2 microg (low concentration), or 20 microg GDF-5 (high concentration). Erectile function was assessed by cavernosal nerve electrostimulation at 8 weeks. Midshaft penile tissue samples were histochemically evaluated for neuronal nitric oxide synthase (nNOS)-containing fibres in the dorsal penile nerve.
RESULTS: There was no erectile dysfunction in the uninjured control group, as shown by a mean (sem) maximal increase in intracavernosal pressure (ICP) of 149.5 (17.0) cmH(2)O on stimulation. By comparison, the ICP decreased in the injured control group, by 21.3 (6.7) cmH(2)O. After cavernosal nerve injury, the recovery of erectile function was greatest in the low-concentration GDF-5 group; the maximum ICP increase was 40.8 (13.3) cmH(2)O, vs 24.3 (5.9) cmH(2)O for 20 microg GDF-5. Histologically, the low-concentration group had significantly more nNOS-containing nerve fibres, at 163 (24.7), than the high-concentration group, at 76 (17.3), or injured controls, at 67 (23.8). By contrast, the uninjured controls had a mean of 538 (40.6) nerve fibres in the dorsal nerve.
CONCLUSION: Bilateral cavernosal nerve crush resulted in erectile dysfunction with accompanying neurological changes in the rat. The intracavernosal application of GDF-5 enhanced the recovery of erectile function and n-NOS nerve preservation, with a 2-microg dose giving the most promising results.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16796696     DOI: 10.1111/j.1464-410X.2006.06375.x

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  5 in total

Review 1.  Potential of adipose-derived stem cells for treatment of erectile dysfunction.

Authors:  Guiting Lin; Lia Banie; Hongxiu Ning; Anthony J Bella; Ching-Shwun Lin; Tom F Lue
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

Review 2.  Nerve growth factor modulation of the cavernous nerve response to injury.

Authors:  Anthony J Bella; Guiting Lin; Ching-Shwun Lin; Duane R Hickling; Christopher Morash; Tom F Lue
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

3.  Transplantation of muscle-derived stem cells into the corpus cavernosum restores erectile function in a rat model of cavernous nerve injury.

Authors:  Jang Chun Woo; Woong Jin Bae; Su Jin Kim; Sung Dae Kim; Dong Wan Sohn; Sung Hoo Hong; Ji Youl Lee; Tae-Kon Hwang; Young Chul Sung; Sae Woong Kim
Journal:  Korean J Urol       Date:  2011-05-24

4.  Neurturin enhances the recovery of erectile function following bilateral cavernous nerve crush injury in the rat.

Authors:  Tom F Lue; Anthony J Bella; Thomas M Fandel; Kavirach Tantiwongse; William O Brant; Robert D Klein; Carlos A Garcia
Journal:  J Brachial Plex Peripher Nerve Inj       Date:  2007-03-06

5.  Preclinical evidence for the benefits of penile rehabilitation therapy following nerve-sparing radical prostatectomy.

Authors:  M Albersen; S Joniau; H Claes; H Van Poppel
Journal:  Adv Urol       Date:  2008
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.